Orthopedic digital imaging developer EOS Imaging has received U.S. Food and Drug Administration (FDA) approval for its spineEOS online 3D spine surgery planning software.
SpineEOS is intended for use in planning surgery for adults who have degenerative spine conditions, as well as for pediatric patients with adolescent idiopathic scoliosis, according to the vendor. Surgeons can use the software to create a treatment plan for achieving optimal sagittal alignment based on pelvic and vertebral 3D data obtained in the functional standing position from an EOS imaging exam, the company said.
The planned surgery and virtual postcorrection 3D anatomy can be used to precisely plan for the 3D shape and length of spinal implants, and it can also be shared preoperatively with patients, EOS said. Surgeons can also access the plans in the operating room through a custom planning report.
EOS believes the software will allow the company to expand its presence in the U.S. spine market, particularly in the complex spine and thoracolumbar fusion surgery markets. Those sectors encompass approximately 400,000 patients per year and represent more than $3 billion in orthopedic implant value, according to the firm.
